Methylation Status of the DAT1 Dopamine Transporter Gene in Individuals With Cannabis Use Disorder: Associations With Personality Traits
Genes, Brain and Behavior · 2025
DOI: 10.1111/gbb.70040 ↗At a glance
Journal article in Genes, Brain and Behavior, 2025. Written by Aleksandra Suchanecka and 5 co-authors. Institution: Independent Laboratory of Behavioral Genetics and Epigenetics, Pomeranian Medical University in Szczecin, Szczecin, Poland. Major MEDLINE topics: Dopamine Plasma Membrane Transport Proteins, DNA Methylation, Personality, Marijuana Abuse. Cited 1 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Science Center.
Abstract (original language)
Cannabis use is a growing public health concern due to its neuropsychiatric consequences and potential epigenetic effects. This study investigated the methylation status of the DAT1 dopamine transporter gene in individuals with cannabis use disorder (CUD) and examined associations with personality traits. A total of 490 male participants (212 with CUD and 278 controls) were assessed using the NEO Five‐Factor Inventory (NEO‐FFI) and the State–Trait Anxiety Inventory (STAI). DNA methylation levels at 33 CpG sites within the DAT1 promoter region were quantified through methylation‐specific PCR and sequencing. Although no significant group differences were found in overall methylation levels, logistic regression revealed significant associations between methylation status and personality dimensions. CUD was linked to higher neuroticism and openness, lower agreeableness and conscientiousness, and elevated anxiety scores. Importantly, reduced DAT1 methylation was a significant predictor of CUD. These findings underscore the interplay between personality, gene regulation, and addiction, supporting a role for epigenetic mechanisms in the development and maintenance of substance use disorders. Future research should explore site‐specific CpG alterations and their longitudinal impact on neurobehavioral outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Independent Laboratory of Behavioral Genetics and Epigenetics, Pomeranian Medical University in Szczecin, Szczecin, Poland.
- Department of Medical Sciences and Public Health, Gdansk University of Physical Education and Sport, Poland.
- Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland.
- Department of Nursing, Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland.
- Second Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin, Lublin, Poland.
ORCID profiles: Aleksandra Suchanecka, Remigiusz Recław, Krzysztof Chmielowiec, Jolanta Chmielowiec, Jolanta Masiak, Anna Grzywacz
Funding
- National Science Center
Cite
APA
Suchanecka, A., Recław, R., Chmielowiec, K., Chmielowiec, J., Masiak, J., & Grzywacz, A. (2025). Methylation Status of the DAT1 Dopamine Transporter Gene in Individuals With Cannabis Use Disorder: Associations With Personality Traits. Genes, Brain and Behavior. https://doi.org/10.1111/gbb.70040
Vancouver
Suchanecka A, Recław R, Chmielowiec K, Chmielowiec J, Masiak J, Grzywacz A. Methylation Status of the DAT1 Dopamine Transporter Gene in Individuals With Cannabis Use Disorder: Associations With Personality Traits. Genes, Brain and Behavior. 2025. doi:10.1111/gbb.70040
BibTeX
@article{Suchanecka2025,
author = {Suchanecka, Aleksandra and Recław, Remigiusz and Chmielowiec, Krzysztof and Chmielowiec, Jolanta and Masiak, Jolanta and Grzywacz, Anna},
title = {Methylation Status of the DAT1 Dopamine Transporter Gene in Individuals With Cannabis Use Disorder: Associations With Personality Traits},
journal = {Genes, Brain and Behavior},
year = {2025},
doi = {10.1111/gbb.70040}
}
EUVIMED